JPRN-UMIN000018913
Recruiting
Phase 4
Effects of SGLT-2 inhibitors for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus. - SGLT-2 and NAFLD/T2DM
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine0 sites50 target enrollmentSeptember 4, 2015
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- on-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.
- Sponsor
- Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) History of allergy to SGLT\-2 inhibitors 2\) HB/HC/autoimmune hepatitis 3\) Pregnancy or lactation in women 4\) Under insulin treatment 5\) Excess alcohol consumption male; \>/\= 30g/day female; \>/\= 20g/day 6\) Inadequacy for this therapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The effects of SGLT2-inhibition in patients with type 2 diabetes and preserved kidney function on renal circulation, kidney function and hormones related to the circulatioType 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]EUCTR2019-004303-12-DKniversity Clinic of Nephrology and Hypertension, Regional Hospital Holstebro20
Recruiting
Not Applicable
Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete.JPRN-UMIN000044317Hokkaido University Hospital200
Completed
Not Applicable
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16
Not yet recruiting
Not Applicable
Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysisChronic kidney disease under peritoneal dialysisJPRN-UMIN000049848International University of Health and Welfare10
Recruiting
Phase 4
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseType 2 Diabetes MellitusObesityC06.552.241.519C18.452.394.750.149RBR-48rxwbCentro Educacional Hyarte